欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0526/001
药品名称
Ringer-Acetat Baxter Viaflo
活性成分
calcium chloride 0.29 mg/ml
magnesium chloride hexahydrate 0.2 mg/ml
potassium chloride 0.3 mg/ml
sodium acetate 4.08 mg/ml
sodium chloride 5.86 mg/ml
剂型
Solution for infusion
上市许可持有人
Baxter Medical AB , Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Denmark (DK)
Ringer-Acetat Baxter Viaflo
Iceland (IS)
Norway (NO)
Finland (FI)
许可日期
2005/07/04
最近更新日期
2024/06/10
药物ATC编码
B05BB01 electrolytes
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Bibliographic [Article 10.1(a)(ii)]
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE/H/0526/001_Final PL
Date of last change:2014/01/15
Final SPC
|
SE/H/0526/001_Final SPC
Date of last change:2014/01/15
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase